The Food and Drug Administration Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle

The U.S. Food and Drug Administration (FDA) announced its determination that the intentional genomic alteration (IGA) of beef cattle for food does not raise any safety concerns (“low-risk determination”). This is the FDA’s first low-risk determination for enforcement discretion regarding an IGA in an animal intended for food production.